Gynion is a Womens Health startup with a mission to offer millions of women worldwide safe, effective, and affordable in-office therapies for common gynecological conditions that improve and save lives. Gynion is developing a therapeutic platform that presents an opportunity to commercialize several products, including Clarablex and Menorrx, addressing unmet needs in several markets with a combined value of $14 Billion.
